Sponsor content
631 result(s) found, displaying 61 to 70
-
Australian public assessment report (AusPar)Yonsa Mpred (abiraterone acetate + methylprednisolone) has been approved for the treatment of metastatic castration resistant prostate cancer and metastatic hormone sensitive prostate cancer.
-
VIVALA ganirelix (as acetate) 250 microgram/0.5 mL solution for injection prefilled syringe (409179)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VIVALA ganirelix (as acetate) 250 microgram/0.5 mL solution for injection prefilled syringe. -
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd
-
Cancellation by sponsorRequested by Sun Pharma ANZ Pty Ltd